Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease.
about
Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?Vascular Remodelling and Mesenchymal Transition in Systemic SclerosisProtein-based therapies for acute lung injury: targeting neutrophil extracellular trapsAlteration of skin properties with autologous dermal fibroblastsPreserved Nephrogenesis Following Partial Nephrectomy in Early Neonates.Genetic tools for identifying and manipulating fibroblasts in the mouseSpeckle tracking echocardiography detects uremic cardiomyopathy early and predicts cardiovascular mortality in ESRD.Translational profiles of medullary myofibroblasts during kidney fibrosis.Kidney pericytes: roles in regeneration and fibrosis.Defining the acute kidney injury and repair transcriptomeRUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiation.Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis.Defective pericyte recruitment of villous stromal vessels as the possible etiologic cause of hydropic change in complete hydatidiform molep70 S6-kinase mediates the cooperation between Akt1 and Mek1 pathways in fibroblast-mediated extracellular matrix remodelingHydrogen Sulfide Donor GYY4137 Protects against Myocardial Fibrosis.Role of Epithelial-Mesenchyme Transition in Chlamydia Pathogenesis.Overexpression of Heme Oxygenase-1 Prevents Renal Interstitial Inflammation and Fibrosis Induced by Unilateral Ureter Obstruction.Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice.Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis.Glycyrrhizic acid alleviates bleomycin-induced pulmonary fibrosis in ratsSpatial expression of components of a calcitonin receptor-like receptor (CRL) signalling system (CRL, calcitonin gene-related peptide, adrenomedullin, adrenomedullin-2/intermedin) in mouse and human heart valves.Stimulation of Transforming Growth Factor-β1-Induced Endothelial-To-Mesenchymal Transition and Tissue Fibrosis by Endothelin-1 (ET-1): A Novel Profibrotic Effect of ET-1.RNA-binding Protein Musashi Homologue 1 Regulates Kidney Fibrosis by Translational Inhibition of p21 and Numb mRNA.Treatment of Rapidly Progressive Systemic Sclerosis: Current and Futures PerspectivesSox10+ adult stem cells contribute to biomaterial encapsulation and microvascularization.Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic diseaseHalofuginone for fibrosis, regeneration and cancer in the gastrointestinal tract.Collagen matrix as a tool in studying fibroblastic cell behavior.Systematic review: the prevention of oesophageal stricture after endoscopic resection.The third path of tubulointerstitial fibrosis: aberrant endothelial secretome.Hedgehog Gli signalling in kidney fibrosis.Endothelial cell-specific activation of transforming growth factor-β signaling in mice induces cutaneous, visceral, and microvascular fibrosis.Effects of chronic alcohol exposure on ischemia-reperfusion-induced acute kidney injury in mice: the role of β-arrestin 2 and glycogen synthase kinase 3.Acceleration Mechanisms of Skin Wound Healing by Autologous Micrograft in Mice.Endoplasmic reticulum stress enhances fibrosis through IRE1α-mediated degradation of miR-150 and XBP-1 splicing.Neutrophil extracellular traps promote differentiation and function of fibroblasts.Novel Mechanism of the Pericyte-Myofibroblast Transition in Renal Interstitial Fibrosis: Core Fucosylation Regulation.Diabetes Aggravates Post-ischaemic Renal Fibrosis through Persistent Activation of TGF-β1 and Shh Signalling.Deregulation of Hippo-TAZ pathway during renal injury confers a fibrotic maladaptive phenotype.Fibroblasts Promote Inflammation and Pain via Interleukin-1α-Induction of the Monocyte Chemoattractant CCL2.
P2860
Q26746104-FA04DA79-4E28-406E-8740-1F93A4A56EA4Q26749091-7058F9E3-BDED-47F2-9FA7-C4A83E38F1C4Q26852032-DA4C5744-B66F-4840-B32C-043C7E1A6B4CQ26998395-2A2CC7A2-88C2-472D-B2CD-C464BC964563Q27349423-D0D23C5B-AD93-494B-B237-527B01393D10Q28392538-BEB7CC6E-A87B-4597-8BFF-7C85EE769E9BQ30401905-0C6ACFCC-F235-462D-B8E4-FECA12B31388Q34103505-DF087565-C947-45F2-8776-4C2B59DC4AAAQ34176024-71FA12ED-A100-46C1-B762-F46473A76983Q34180380-0756EC74-1401-4C9F-8D49-E312283EC9B5Q34581160-57880F99-E3DB-4012-9721-582FB7FD567DQ34899171-341E04DA-F4AB-444C-B54E-47705D651374Q35303697-634E1444-A77E-460D-993B-1CAC60E80113Q35598268-78F8B825-E637-401C-8950-86CCAEA2DA65Q35640723-A7F93B20-A534-4398-AE77-8686E2D9CB25Q35872623-C076CE27-B15C-4ED2-AC89-EEAB76B3AFC3Q35893756-9523F63F-2071-49E0-8544-594053395654Q35923493-1BBF39BB-45EF-4C0D-824B-DD17599B6090Q36040432-15F665F6-30DE-4A08-B597-678B86EF2C77Q36109719-89F26F90-BF7F-4AFD-8D4C-1782E3F3C178Q36110798-1DF7E532-DD4B-4F36-A903-FA95114D3262Q36119874-E89E16BD-BDA2-4612-A13F-4509572D353CQ37065716-6D4B0A2E-6483-45E9-AAA3-9CDE11B4AD08Q37381549-16299EEE-F49E-4BA5-95CA-A8A940A4218AQ37575859-D243D77D-FE5B-4B3F-82E1-654EABAF879FQ38202115-D35DC03B-573A-464E-9BCC-A9AD64CC941CQ38263852-B97A3DE8-0027-405C-ACB7-782AFD953B2CQ38367153-77FD73B8-8547-4E3F-9625-2DB17BDEAA76Q38485909-235364EF-7724-41B3-864F-66735AC1FECFQ38687181-B9838CD2-2B53-497C-BA32-C5AE55831E22Q38845233-0818F0F4-BF60-4731-A2E0-BD51A7897971Q38873978-18828E46-58E1-4AA7-BEF7-F238315F3E2DQ41071174-76A05F23-C5F2-4D14-A742-67BA6B8F6BE0Q41573427-955233C5-4649-44C5-BB81-10CD5DA85D67Q41811106-EF8DF9E0-1EEB-41E6-8A9D-F00B69B936D4Q43656654-96EA9EBE-70FB-4994-A078-EA9EBD8EAE1AQ47112638-E7C53756-5AE5-43F0-B4E1-CF37BB01ABF4Q47139581-47429F66-0E09-4160-BA61-81ED1124C987Q47234424-5DF234E1-41BA-4302-A656-FEAAE20F233BQ47285409-7955DDE8-BE9A-4ABC-835D-984026A60AFE
P2860
Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Understanding the origin, acti ...... treatment of fibrotic disease.
@en
type
label
Understanding the origin, acti ...... treatment of fibrotic disease.
@en
prefLabel
Understanding the origin, acti ...... treatment of fibrotic disease.
@en
P2860
P356
P1476
Understanding the origin, acti ...... treatment of fibrotic disease
@en
P2093
Benjamin D Humphreys
Derek P DiRocco
P2860
P304
P356
10.1002/PATH.4253
P577
2013-11-01T00:00:00Z